Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Proximagen begins phase II PRX-167700 study of knee osteoarthritis

Sep. 27, 2013

EMA committee recommends approval of Cimzia in new indication

Sep. 25, 2013

Novel tricyclic S1P1 modulators disclosed by Bristol-Myers Squibb

Sep. 16, 2013

First biosimilar monoclonal antibody approved in Europe

Sep. 12, 2013

Cellular Biomedicine reports phase I/IIa cell therapy trial data for knee osteoarthritis

Sep. 9, 2013

Novartis receives E.U. approval for Ilaris in active systemic juvenile idiopathic arthritis

Sep. 4, 2013

New IL-1 beta antibodies disclosed by researchers in Singapore

Sep. 3, 2013

Epirus Biopharmaceuticals reports phase III data on biosimilar infliximab product

Aug. 30, 2013

Subcutaneous Orencia launched in Japan for rheumatoid arthritis

Aug. 28, 2013

FDA accepts Pennsaid 2% NDA for review

Aug. 23, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...